Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.4K Buy
962
+6
+0.6% +$310 0.04% 352
2026
Q1
$47.9K Sell
956
-12
-1% -$560 0.03% 402
2025
Q4
$28.5K Buy
968
+60
+7% +$1.63K 0.02% 461
2025
Q3
$23.5K Buy
908
+30
+3% +$837 0.02% 476
2025
Q2
$24K Buy
+878
New +$23.1K 0.02% 469

Other funds holding MRNA

OneFund LLC's MRNA Position: Q2 2026 in Review

OneFund LLC increased its Moderna (MRNA) stake by 0.63% in Q2 2026, buying an estimated $310 and bringing the position to 962 shares worth $67.4K. The position accounts for 0.04% of the portfolio, ranked #352.

OneFund LLC first reported a position in MRNA in Q2 2025 and has held it in 5 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • OneFund LLC held 962 shares of Moderna worth $67.4K as of Q2 2026.
  • OneFund LLC bought 6 Moderna shares in Q2 2026, an estimated $310.
  • Moderna made up 0.04% of OneFund LLC's portfolio in Q2 2026, its #352 holding.
  • OneFund LLC first reported a position in Moderna in Q2 2025 and has held it in 5 quarters since.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on OneFund LLC's 13F filing for Q2 2026, filed 24 Aug 2026.